BioLife Solutions (BLFS) Receives 7 Additional Patents

Go back to BioLife Solutions (BLFS) Receives 7 Additional Patents

BioLife Solutions Expands Intellectual Property Estate

November 21, 2022 8:05 AM UTC

7 New Granted Patents; 43 Submitted Patent Applications

Global Portfolio Now Totals 148 Issued and 114 Pending Patents

BOTHELL, Wash., Nov. 21, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today provided an update on the expansion of its intellectual property... More